Price of BBIO with the Market Cap of NBIX
If BridgeBio Pharma, Inc. (BBIO) had the market cap of Neurocrine Biosciences, Inc. (NBIX), one BBIO would cost $87.19, 1.10 times today's price of $79.54. The market cap of Neurocrine Biosciences, Inc. ($17.09B) is 1.10 times that of BridgeBio Pharma, Inc. ($15.59B).
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
BridgeBio Pharma, Inc. vs Neurocrine Biosciences, Inc.: key figures
| Rank | #1420 | #1318 |
|---|---|---|
| Price | $79.54 | $168.86 |
| Market cap | $15.59B | $17.09B |
| Shares Outstanding | 196.03M | 101.22M |
| Change (1 day) | +1.11% | +2.57% |
| Change (1 year) | +22.26% | +17.13% |
The other way round: NBIX with the market cap of BBIO
If Neurocrine Biosciences, Inc. (NBIX) had the market cap of BridgeBio Pharma, Inc. (BBIO), one NBIX would cost $154.04, 8.77% less than today's price of $168.86.
Price of NBIX with the Market Cap of BBIOPrice of BBIO with the Market Cap of NBIX: the last 12 months
The price of one BBIO if BridgeBio Pharma, Inc. had the market cap of Neurocrine Biosciences, Inc., at the end of each month. Highest: $87.74 (Nov 2026). Lowest: $66.42 (Apr 2026).
- $74.00 Dec 2025
- $70.99 Jan 2026
- $66.72 Feb 2026
- $66.46 Mar 2026
- $66.42 Apr 2026
- $81.67 May 2026
- $86.96 Jun 2026
- $85.86 Jul 2026
- $79.07 Aug 2026
- $72.82 Sep 2026
- $76.24 Oct 2026
- $87.74 Nov 2026
Questions about BridgeBio Pharma, Inc. and Neurocrine Biosciences, Inc.
What would the price of BridgeBio Pharma, Inc. be with the market cap of Neurocrine Biosciences, Inc.?
If BridgeBio Pharma, Inc. (BBIO) had the market cap of Neurocrine Biosciences, Inc. (NBIX), one BBIO would cost $87.19, 1.10 times today's price of $79.54.
How much bigger is Neurocrine Biosciences, Inc. than BridgeBio Pharma, Inc.?
The market cap of Neurocrine Biosciences, Inc. ($17.09B) is 1.10 times that of BridgeBio Pharma, Inc. ($15.59B). In Dec 2025 it was the other way round: BridgeBio Pharma, Inc. was 1.03 times bigger than Neurocrine Biosciences, Inc..
What would the price of Neurocrine Biosciences, Inc. be with the market cap of BridgeBio Pharma, Inc.?
If Neurocrine Biosciences, Inc. (NBIX) had the market cap of BridgeBio Pharma, Inc. (BBIO), one NBIX would cost $154.04, 8.77% less than today's price of $168.86.
How is this price calculated?
The market cap of Neurocrine Biosciences, Inc. ($17.09B) is divided by the number of BBIO in circulation (196.03M). Market cap is the price multiplied by the number of coins or shares in circulation.